hemophagocytic lymphohistiocytosis complicating dengue and plasmodium vivax coinfection
Clicks: 202
ID: 239390
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
202 views
33 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #79 of 309 articles by views in Frontiers in pharmacology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 309 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder. Dysfunction of cytotoxic T and natural killer (NK) cells causes uncontrolled activity of lymphocytes and histiocytes which leads to HLH. Infections, malignancies, and autoimmune disorders are associated with development of HLH. Dengue and Plasmodium vivax are rare causes of HLH. We report the first ever case of a young man who developed fatal HLH that complicated Dengue Hemorrhagic Fever (DHF) and Plasmodium vivax infection.
| Reference Key |
khurram2015casehemophagocytic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Muhammad Khurram;Muhammad Faheem;Muhammad Umar;Asif Yasin;Wajeeha Qayyum;Amna Ashraf;Javeria Zahid Khan;Ali Hasnain Yasir;Yusra Ansari;Muhammad Asad;Iram Khan;Shuja Abbas;Irum Rasheed;Natasha Rasool;Hamama Tul Bushra Khar |
| Journal | Frontiers in pharmacology |
| Year | 2015 |
| DOI |
10.1155/2015/696842
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.